FR2325371B1 - - Google Patents

Info

Publication number
FR2325371B1
FR2325371B1 FR7629245A FR7629245A FR2325371B1 FR 2325371 B1 FR2325371 B1 FR 2325371B1 FR 7629245 A FR7629245 A FR 7629245A FR 7629245 A FR7629245 A FR 7629245A FR 2325371 B1 FR2325371 B1 FR 2325371B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7629245A
Other languages
French (fr)
Other versions
FR2325371A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2325371A1 publication Critical patent/FR2325371A1/fr
Application granted granted Critical
Publication of FR2325371B1 publication Critical patent/FR2325371B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FR7629245A 1975-09-29 1976-09-29 Homologues de prostaglandines Granted FR2325371A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/617,481 US4065472A (en) 1975-09-29 1975-09-29 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins

Publications (2)

Publication Number Publication Date
FR2325371A1 FR2325371A1 (fr) 1977-04-22
FR2325371B1 true FR2325371B1 (US20030199744A1-20031023-C00003.png) 1978-12-22

Family

ID=24473823

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7629245A Granted FR2325371A1 (fr) 1975-09-29 1976-09-29 Homologues de prostaglandines

Country Status (11)

Country Link
US (1) US4065472A (US20030199744A1-20031023-C00003.png)
JP (1) JPS5242872A (US20030199744A1-20031023-C00003.png)
BE (1) BE846650A (US20030199744A1-20031023-C00003.png)
CA (1) CA1085832A (US20030199744A1-20031023-C00003.png)
DE (1) DE2640692C3 (US20030199744A1-20031023-C00003.png)
DK (1) DK435276A (US20030199744A1-20031023-C00003.png)
FR (1) FR2325371A1 (US20030199744A1-20031023-C00003.png)
GB (1) GB1508925A (US20030199744A1-20031023-C00003.png)
IE (1) IE44067B1 (US20030199744A1-20031023-C00003.png)
LU (1) LU75904A1 (US20030199744A1-20031023-C00003.png)
NL (1) NL7610761A (US20030199744A1-20031023-C00003.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
BRPI0818902A2 (pt) * 2007-11-09 2015-05-12 Allergan Inc Ciclopentanos substituídos tendo atividade de prostaglandina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350971A (en) 1971-05-11 1974-04-24 Imp Chemi Als Ind Ltd Cyclopentane derivatives
US3922289A (en) * 1973-02-23 1975-11-25 Syntex Inc Trans-prostaglandin-like compounds and methods

Also Published As

Publication number Publication date
LU75904A1 (US20030199744A1-20031023-C00003.png) 1977-05-11
IE44067B1 (en) 1981-08-12
GB1508925A (en) 1978-04-26
DE2640692A1 (de) 1977-03-31
JPS5242872A (en) 1977-04-04
JPS5437136B2 (US20030199744A1-20031023-C00003.png) 1979-11-13
FR2325371A1 (fr) 1977-04-22
DE2640692B2 (US20030199744A1-20031023-C00003.png) 1979-01-18
US4065472A (en) 1977-12-27
CA1085832A (en) 1980-09-16
DK435276A (da) 1977-03-30
IE44067L (en) 1977-03-29
NL7610761A (nl) 1977-03-31
BE846650A (fr) 1977-03-28
DE2640692C3 (de) 1979-09-13

Similar Documents

Publication Publication Date Title
FR2322617B1 (US20030199744A1-20031023-C00003.png)
JPS5221410U (US20030199744A1-20031023-C00003.png)
FR2325371B1 (US20030199744A1-20031023-C00003.png)
FI762152A (US20030199744A1-20031023-C00003.png)
JPS5223833U (US20030199744A1-20031023-C00003.png)
JPS5242541U (US20030199744A1-20031023-C00003.png)
FR2328484B1 (US20030199744A1-20031023-C00003.png)
JPS5546727B2 (US20030199744A1-20031023-C00003.png)
JPS51148936U (US20030199744A1-20031023-C00003.png)
JPS5217788U (US20030199744A1-20031023-C00003.png)
JPS522694U (US20030199744A1-20031023-C00003.png)
JPS5229956U (US20030199744A1-20031023-C00003.png)
CH588715A5 (US20030199744A1-20031023-C00003.png)
CH593355A5 (US20030199744A1-20031023-C00003.png)
BG23303A1 (US20030199744A1-20031023-C00003.png)
CH326375A4 (US20030199744A1-20031023-C00003.png)
CH594920A5 (US20030199744A1-20031023-C00003.png)
CH582328A5 (US20030199744A1-20031023-C00003.png)
CH595405A5 (US20030199744A1-20031023-C00003.png)
CH596057A5 (US20030199744A1-20031023-C00003.png)
CH586879A5 (US20030199744A1-20031023-C00003.png)
CH587680A5 (US20030199744A1-20031023-C00003.png)
CH593414A5 (US20030199744A1-20031023-C00003.png)
CH592518A5 (US20030199744A1-20031023-C00003.png)
CH598077A5 (US20030199744A1-20031023-C00003.png)

Legal Events

Date Code Title Description
ST Notification of lapse